Submicroscopic carriage of Plasmodium falciparum and Plasmodium vivax in a low endemic area in Ethiopia where no parasitaemia was detected by microscopy or rapid diagnostic test
Open Access
- 5 August 2015
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 14 (1) , 1-7
Abstract
Motivated by the success in malaria control that was documented over the last decade Ethiopia is aiming at malaria elimination by 2020 in selected districts. It is currently unknown if asymptomatic, submicroscopic malaria parasite carriage may form a hurdle to achieve elimination. The elimination effort may further be complicated by possible glucose-6 phosphate dehydrogenase (G6PD) deficiency which would hinder the use of 8-aminoquinolines in the elimination efforts. In February 2014 a community-based cross-sectional survey was conducted in Malo, southwest Ethiopia. Finger-prick blood samples (n = 555) were tested for presence of Plasmodium falciparum and Plasmodium vivax with microscopy, rapid diagnostic test (RDT), and nested polymerase chain reaction (nPCR). Multiplicity of P. falciparum infections was determined based on genotyping the polymorphic merozoite surface protein-2 (MSP-2) gene. Individuals were also genotyped for mutations in the gene that produces G6PD. All study participants were malaria infection negative by microscopy and RDT. Nested PCR revealed P. falciparum mono-infection in 5.2% (29/555), P. vivax mono-infection in 4.3% (24/555) and mixed infection in 0.2% (1/555) of individuals. All parasitemic individuals were afebrile (axillary temperature <37.5°C). None of the study participants carried mutations for the G6PD African A-(202GA) and Mediterranean (563CT) variants. All infections, except one, were single-clone infection by MSP-2 genotyping. The detection of a substantial number of subpatent malaria infections in an apparently asymptomatic population without evidence for malaria transmission by conventional diagnostics raises questions about the path to malaria elimination. It is currently unknown how important these infections are for sustaining malaria transmission in the study sites. The absence of G6PD deficiency indicates that 8-aminoquinolines may be safely deployed to accelerate elimination initiatives.Keywords
Funding Information
- The Netherlands organization for international cooperation in higher education (Nuffic) (NFP-PhD.14/150)
- Addis Ababa University (Ethiopia)
This publication has 40 references indexed in Scilit:
- Infectiousness of the Human Population to Anopheles arabiensis by Direct Skin Feeding in an Area Hypoendemic for Malaria in SenegalThe American Journal of Tropical Medicine and Hygiene, 2015
- Mass Screening and Treatment on the Basis of Results of a Plasmodium falciparum-Specific Rapid Diagnostic Test Did Not Reduce Malaria Incidence in ZanzibarThe Journal of Infectious Diseases, 2014
- Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest EthiopiaMalaria Journal, 2014
- Primaquine to prevent transmission of falciparum malariaThe Lancet Infectious Diseases, 2013
- Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is commonMalaria Journal, 2012
- School-based surveys of malaria in Oromia Regional State, Ethiopia: a rapid survey method for malaria in low transmission settingsMalaria Journal, 2011
- Shrinking the malaria map: progress and prospectsThe Lancet, 2010
- The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysisBlood Cells, Molecules, and Diseases, 2009
- 2. Genotypes of merozoite surface protein 2 of Plasmodium falciparum in TanzaniaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Heterologous Immunity in Human MalariaThe Quarterly Review of Biology, 1973